Jorge Cortes, Moshe Talpaz, Hedy P. Smith, David S. Snyder, Jean Khoury, Kapil N. Bhalla, Javier Pinilla-Ibarz, Richard Larson, David Mitchell, Scott C. Wise, Thomas J. Rutkoski, Bryan D. Smith, Daniel L. Flynn, Hagop M. Kantarjian, Oliver Rosen, and Richard A. Van Etten. 2017. “Phase 1 Dose-Finding Study of Rebastinib (DCC-2036) in Patients With Relapsed Chronic Myeloid Leukemia and Acute Myeloid Leukemia”. Haematologica 102 (3). Pavia, Italy, 519-28. https://doi.org/10.3324/haematol.2016.152710.